BUL: THQM Statistics

Total Valuation

Tchaikapharma High Quality Medicines AD has a market cap or net worth of BGN 1.65 billion. The enterprise value is 1.66 billion.

Market Cap	1.65B
Enterprise Value	1.66B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Tchaikapharma High Quality Medicines AD has 91.80 million shares outstanding. The number of shares has decreased by -0.41% in one year.

Current Share Class	n/a
Shares Outstanding	91.80M
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	-6.49%
Owned by Insiders (%)	81.10%
Owned by Institutions (%)	n/a
Float	11.55M

Valuation Ratios

The trailing PE ratio is 327.99.

PE Ratio	327.99
Forward PE	n/a
PS Ratio	31.09
PB Ratio	15.02
P/TBV Ratio	15.52
P/FCF Ratio	1,380.45
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 199.24, with an EV/FCF ratio of 1,389.68.

EV / Earnings	330.18
EV / Sales	31.30
EV / EBITDA	199.24
EV / EBIT	284.35
EV / FCF	1,389.68

Financial Position

The company has a current ratio of 5.82, with a Debt / Equity ratio of 0.10.

Current Ratio	5.82
Quick Ratio	4.29
Debt / Equity	0.10
Debt / EBITDA	1.33
Debt / FCF	9.30
Interest Coverage	10.12

Financial Efficiency

Return on equity (ROE) is 4.69% and return on invested capital (ROIC) is 3.08%.

Return on Equity (ROE)	4.69%
Return on Assets (ROA)	2.93%
Return on Capital (ROIC)	3.08%
Revenue Per Employee	256,720
Profits Per Employee	24,338
Employee Count	191
Asset Turnover	0.43
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.88% in the last 52 weeks. The beta is 0.03, so Tchaikapharma High Quality Medicines AD's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+5.88%
50-Day Moving Average	17.55
200-Day Moving Average	16.74
Relative Strength Index (RSI)	63.26
Average Volume (20 Days)	213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tchaikapharma High Quality Medicines AD had revenue of BGN 53.14 million and earned 5.04 million in profits. Earnings per share was 0.05.

Revenue	53.14M
Gross Profit	17.75M
Operating Income	5.85M
Pretax Income	5.62M
Net Income	5.04M
EBITDA	7.73M
EBIT	5.85M
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 79,000 in cash and 11.13 million in debt, giving a net cash position of -11.05 million or -0.12 per share.

Cash & Cash Equivalents	79,000
Total Debt	11.13M
Net Cash	-11.05M
Net Cash Per Share	-0.12
Equity (Book Value)	110.05M
Book Value Per Share	1.20
Working Capital	69.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.37 million and capital expenditures -2.17 million, giving a free cash flow of 1.20 million.

Operating Cash Flow	3.37M
Capital Expenditures	-2.17M
Free Cash Flow	1.20M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 33.41%, with operating and profit margins of 11.01% and 9.48%.

Gross Margin	33.41%
Operating Margin	11.01%
Pretax Margin	10.58%
Profit Margin	9.48%
EBITDA Margin	14.55%
EBIT Margin	11.01%
FCF Margin	2.25%

Dividends & Yields

Tchaikapharma High Quality Medicines AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	0.41%
Earnings Yield	0.30%
FCF Yield	0.07%

Stock Splits

The last stock split was on July 3, 2023. It was a forward split with a ratio of 1.0508876.

Last Split Date	Jul 3, 2023
Split Type	Forward
Split Ratio	1.0508876

Scores

Tchaikapharma High Quality Medicines AD has an Altman Z-Score of 57.49.

Altman Z-Score	57.49
Piotroski F-Score	n/a